Generics in Asia-Pacific
Generics
| Publication Date | September 2009 |
|---|---|
| Publisher | Datamonitor |
| Product Type | Report |
| Pages | 31 |
| ISBN Number | not applicable |
| Product Code | DAT00874 |
Buy this product or for assistance call +44 20 7060 7474
Summary
Datamonitor's Generics in Asia-Pacific industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.
Scope
- Contains an executive summary and data on value, volume and/or segmentation
- Provides textual analysis of the industry's recent performance and future prospects
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Includes a five-year forecast of the industry
- The leading companies are profiled with supporting key financial metrics
- Supported by the key macroeconomic and demographic data affecting the market
Highlights
- Detailed information is included on market size, measured by value and/or volume
- Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
Why you should buy this report
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Market Definition
The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. Datamonitor defines a generic as an officially-approved copy of an original product whose patent has expired, marketed either as a brand or using the generic name.
This definition excludes multi-source copy products, that make up much of markets such as India, Spain and Italy. Multi-source copies are drugs still under patent that are offered by manufacturers other than the patent holders. All currency conversions have been calculated at constant 2008 average exchange rates.
For the purpose of this report Asia-Pacific is deemed to comprise of Australia, China, Japan, India, Singapore, South Korea and Taiwan.
The global figure is deemed to comprise of the Americas, Asia-Pacific and Europe.
The Americas comprises Argentina, Brazil, Canada, Chile, Colombia, Mexico, Venezuela, and the US.
Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, the Ukraine and the United Kingdom.
Content
- Executive Summary
- Chapter 1 Market Overview
- 1.1 Market Definition
- 1.2 Research Highlights
- 1.3 Market Analysis
- Chapter 2 Market Value
- Chapter 3 Market Segmentation I
- Chapter 4 Market Segmentation Ii
- Chapter 5 Five Forces Analysis
- 5.1 Summary
- 5.2 Buyer Power
- 5.3 Supplier Power
- 5.4 New Entrants
- 5.5 Substitutes
- 5.6 Rivalry
- Chapter 6 Leading Companies
- 6.1 ASKA Pharmaceutical Co., Ltd
- 6.2 Sawai Pharmaceuticals
- 6.3 Wuhan Grand Pharmaceutical Group
- 6.4 STADA Arzneimittel AG
- Chapter 7 Market Forecasts
- 7.1 Market Value Forecast
- Chapter 8 Appendix
- 8.1 Methodology
- 8.2 Industry Associations
- 8.3 Related Datamonitor Research
- List of Tables
- Table 1: Asia-Pacific Generics Market Value: $ billion, 2004-2008
- Table 2: Asia-Pacific Generics Market Segmentation I: % Share, by Value, 2008
- Table 3: Asia-Pacific Generics Market Segmentation II: % Share, by Value, 2008
- Table 4: Key Facts: ASKA Pharmaceutical Co., Ltd
- Table 5: Key Financials: ASKA Pharmaceutical Co., Ltd
- Table 6: Key Facts: Sawai Pharmaceuticals
- Table 7: Key Financials: Sawai Pharmaceuticals
- Table 8: Key Facts: Wuhan Grand Pharmaceutical Group
- Table 9: Key Facts: STADA Arzneimittel AG
- Table 10: Key Financials: STADA Arzneimittel AG
- Table 11: Asia-Pacific Generics Market Value Forecast: $ billion, 2008-2013
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
Related Products
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories











